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Britta Girndt, MS,b Martin Großherr, MD,c Mathias Klinger, MD,d and Hans H. Sievers, MD,a
Nu¨rnberg and Lu¨beck, GermanyAt present, 275 000 heart valve replacements are performed
annually world wide. Roughly 60% are glutaraldehyde-
fixed tissue valve prostheses. Glutaraldehyde-fixed tissues
such as bovine pericardium and porcine heart valves are
the commonly used base materials for the construction of
bioprosthetic heart valves as substitutes in humans. How-
ever, premature degradation limits valve durability, espe-
cially in younger patients. Cell-coated blood-contacting
surfaces of glutaraldehyde-fixed biological heart valves are
hypothesized to improve biocompatibility and durability.1
The toxicity of glutaraldehyde, however, prevents biological
coating if not partially detoxified and preseeded by fibro-
blasts followed by endothelial cell seeding in vitro.1
Titanium has proven itself to be the leading structured me-
tallic biomaterial for 50 years.2 Theoretically, surface coat-
ing of the less biocompatible glutaraldehyde-treated tissue
with titanium may open new avenues for improving biocom-
patibility. However, a titanium coating on biomaterials
seemed not to be possible until now owing to the high tem-
peratures needed for commonly used sputtering techniques.
Therefore, a coating method was applied for a biological
substrate, using a plasma-activated chemical vapor deposi-
tion with the gaseous precursor TMT (tetrakisdimethyl-ami-
dotitanium, Ti[N(CH3)2]4) at low pressure and temperatures
of 30C to 35C.3 In addition to titanium coating, a technique
for partial detoxification with citric acid (CA10%), as de-
scribed elsewhere,1 was applied on self-prepared glutaralde-
hyde-fixed (0.25% over 24 hours) aortic porcine valves.
HETEROTOPIC AORTIC VALVE IMPLANT
Implantation of a preseeded aortic valve in the descending
aortic position in a sheep model without extracorporal circu-
lation has already been described.1 We used a male Bore
goat with a weight of 83 kg (ethical accreditation of the
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6) to create a muscular blood pump in the descending aortic
position (Figure 1). We integrated two glutaraldehyde-fixed,
titanium-coated and detoxified porcine heart valves into the
inflow and outflow part of the pumping chamber of this mus-
cular blood pump, the biomechanical heart.4 This skeletal
muscle ventricle pumped with a frequency of 20 beats/
min. After 6 months of pumping, the valves were removed
from the pumping chamber for histologic analysis.
HISTOLOGIC AND IMMUNOHISTOCHEMICAL
STAINING
Valve leaflets from the two valves were embedded in par-
affin, cut into sections of 4 mm, and treated with a hematoxy-
lin–eosin stain (Figure 2, B). Other sections were treated
using polyclonal antibodies against factor VIII (Dako, Ham-
burg, Germany). After incubation with primary antibody, an
anti-rabbit immunoglobulin G antibody was applied that was
conjugated with alkaline phosphatase (Sigma-Steinheim,
Germany). Finally, substrate incubation (naphtole/neofuch-
sine, Dako) and counterstaining with hemalaun were per-
formed (Figure 2, C). Others samples were conjugated with
the fluorescence marker fluorescein isothiocyanate porc
anti-rabbit immunoglobulin G (Dako,) and diluted 1:50 in
10% human serum (Figure 2, D). Cell nuclei were counter-
stained with propidium iodide (Sigma-Steinheim, Germany)
diluted 1:500 in phosphate-buffered solution (Dako,
FIGURE 1. Valve topography within the inflow and outflow part of the
pumping chamber of a biomechanical heart, a muscular blood pump within
the aorto–aortic position.rgery c July 2009
Brief Research ReportsFIGURE 2. Porcine detoxified and titanized aortic valve, having been implanted heterotopically within the aorta of a goat for 6 months, is in good condition
(A). Cross section of a valve leaflet (B) shows recellularization of the blood-contacting surface (hematoxylin–eosin stain, magnification 203). Immunhisto-
chemic staining against von Willebrand factor proves endothelialization of the blood-contacting surface, labeled with alkaline phosphatase (C) and visualized
with immunofluorescence (D).Hamburg, Germany). Photographic documentation was
performed by using a magnification of 203.
RESULTS
Porcine titanized and detoxified aortic valves, having
been implanted heterotopically within the systemic circula-
tion of a goat for 6 months, were macroscopically well
(Figure 2, A) and showed a normal opening and closure
behavior. Cross section of a valve leaflet (Figure 2, B)
demonstrated a cell-seeding of its blood-contacting surface
(hematoxylin–eosin staining, magnification 203). Immun-
histochemical staining against factor VIII proved a complete
endothelialization of the total blood-contacting surface, la-
beled with alkaline phosphatase (Figure 2, C) and visualized
with immunofluorescence (Figure 2, D).
CONCLUSIONS
Tissue engineering of heart valves is considered to
be a hopeful concept to generate improved substitute
bioprostheses. However, because there is yet no realiz-
able blueprint to construct semilunar valves,5 our aim
was to refine conventional, proven bioprostheses using
innovative nanotechnologies such as plasma depositionThe Journal of Thoracic and Cwith the most biocompatible titanium coating in combi-
nation with chemical agents like citric acid and alde-
hyde dehydrogenase. This procedure has been shown
to support detoxification and endothelialization of bio-
logical glutaraldehyde-fixed tissue.
This newly developed method combining tissue engineer-
ing with nanotechnology, including a titanium coating, cre-
ated the first self-seeded glutaraldehyde-fixed biological
heart valve within the circulation under arterial pressure. It
might open a new field of research for developing new heart
valves with improved durability and function. This new tech-
nology might also be appropriate for creating endothelialized
vascular prostheses with small diameters and the potential of
a self-seeding blood-contacting surface accompanied by
a hypothesized high patency rate, in aorta–coronary bypass
surgery as well as in peripheral limb surgery. Further large
animal studies are necessary to approve this procedure to
increase durability and function in biological glutaralde-
hyde-fixed heart valves over several decades and avoid
reoperations caused by valve degeneration.
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